Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells

Castleman’s disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nephrology 2014-06, Vol.81 (6), p.445-450
Hauptverfasser: Wakabayashi, Keiichi, Asanuma, Katsuhiko, Takeda, Yukihiko, Arakawa, Atsushi, Osawa, Isao, Horikoshi, Satoshi, Yao, Takashi, Tomino, Yasuhiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 450
container_issue 6
container_start_page 445
container_title Clinical nephrology
container_volume 81
creator Wakabayashi, Keiichi
Asanuma, Katsuhiko
Takeda, Yukihiko
Arakawa, Atsushi
Osawa, Isao
Horikoshi, Satoshi
Yao, Takashi
Tomino, Yasuhiko
description Castleman’s disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case.
doi_str_mv 10.5414/CN107705
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1545189808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1545189808</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-6174baa3b3a838c01e86889b0e400d1623ec2cc7552b50970e97b62660eefacf3</originalsourceid><addsrcrecordid>eNo1kMtOwzAURL0A0VKQ-ALkHWwC13aeSxQBRapgA-voxrmhrhwnxA6of0_KYzWbmaOjYexCwE0Si_i2fBaQZZAcsSUoEBHEChbs1PsdgIRc5SdsIZUUQqliyXbrPVrjiH-i15PFkYf9QLxv-eSMJhdGo3mJPljq0F153hhP6Il_mbDlw9hb09KIwfTuMHq3fUfjD4dc04ctWYOWa7LWn7HjFq2n879csbeH-9dyHW1eHp_Ku000zFIhSkUW14iqVjjLahCUp3le1EAxQCNSqUhLrbMkkXUCRQZUZHUq0xSIWtStWrHrX-5s9zGRD1Vn_MEAHfWTr0QSJyIv8vmLFbv8q051R001jKbDcV_9_6O-AW2VZXw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1545189808</pqid></control><display><type>article</type><title>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Wakabayashi, Keiichi ; Asanuma, Katsuhiko ; Takeda, Yukihiko ; Arakawa, Atsushi ; Osawa, Isao ; Horikoshi, Satoshi ; Yao, Takashi ; Tomino, Yasuhiko</creator><creatorcontrib>Wakabayashi, Keiichi ; Asanuma, Katsuhiko ; Takeda, Yukihiko ; Arakawa, Atsushi ; Osawa, Isao ; Horikoshi, Satoshi ; Yao, Takashi ; Tomino, Yasuhiko</creatorcontrib><description>Castleman’s disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case.</description><identifier>ISSN: 0301-0430</identifier><identifier>DOI: 10.5414/CN107705</identifier><identifier>PMID: 23211339</identifier><language>eng</language><publisher>Germany</publisher><subject>Aged ; Biomarkers - blood ; Biopsy ; Castleman Disease - blood ; Castleman Disease - drug therapy ; Castleman Disease - pathology ; Cell Proliferation - drug effects ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelial Cells - pathology ; Female ; Humans ; Immunohistochemistry ; Immunosuppressive Agents - therapeutic use ; Interleukin-6 - blood ; Kidney Glomerulus - drug effects ; Kidney Glomerulus - metabolism ; Kidney Glomerulus - pathology ; Treatment Outcome ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>Clinical nephrology, 2014-06, Vol.81 (6), p.445-450</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23211339$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wakabayashi, Keiichi</creatorcontrib><creatorcontrib>Asanuma, Katsuhiko</creatorcontrib><creatorcontrib>Takeda, Yukihiko</creatorcontrib><creatorcontrib>Arakawa, Atsushi</creatorcontrib><creatorcontrib>Osawa, Isao</creatorcontrib><creatorcontrib>Horikoshi, Satoshi</creatorcontrib><creatorcontrib>Yao, Takashi</creatorcontrib><creatorcontrib>Tomino, Yasuhiko</creatorcontrib><title>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</title><title>Clinical nephrology</title><addtitle>Clin Nephrol</addtitle><description>Castleman’s disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case.</description><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Castleman Disease - blood</subject><subject>Castleman Disease - drug therapy</subject><subject>Castleman Disease - pathology</subject><subject>Cell Proliferation - drug effects</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial Cells - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Interleukin-6 - blood</subject><subject>Kidney Glomerulus - drug effects</subject><subject>Kidney Glomerulus - metabolism</subject><subject>Kidney Glomerulus - pathology</subject><subject>Treatment Outcome</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>0301-0430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMtOwzAURL0A0VKQ-ALkHWwC13aeSxQBRapgA-voxrmhrhwnxA6of0_KYzWbmaOjYexCwE0Si_i2fBaQZZAcsSUoEBHEChbs1PsdgIRc5SdsIZUUQqliyXbrPVrjiH-i15PFkYf9QLxv-eSMJhdGo3mJPljq0F153hhP6Il_mbDlw9hb09KIwfTuMHq3fUfjD4dc04ctWYOWa7LWn7HjFq2n879csbeH-9dyHW1eHp_Ku000zFIhSkUW14iqVjjLahCUp3le1EAxQCNSqUhLrbMkkXUCRQZUZHUq0xSIWtStWrHrX-5s9zGRD1Vn_MEAHfWTr0QSJyIv8vmLFbv8q051R001jKbDcV_9_6O-AW2VZXw</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Wakabayashi, Keiichi</creator><creator>Asanuma, Katsuhiko</creator><creator>Takeda, Yukihiko</creator><creator>Arakawa, Atsushi</creator><creator>Osawa, Isao</creator><creator>Horikoshi, Satoshi</creator><creator>Yao, Takashi</creator><creator>Tomino, Yasuhiko</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20140601</creationdate><title>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</title><author>Wakabayashi, Keiichi ; Asanuma, Katsuhiko ; Takeda, Yukihiko ; Arakawa, Atsushi ; Osawa, Isao ; Horikoshi, Satoshi ; Yao, Takashi ; Tomino, Yasuhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-6174baa3b3a838c01e86889b0e400d1623ec2cc7552b50970e97b62660eefacf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Castleman Disease - blood</topic><topic>Castleman Disease - drug therapy</topic><topic>Castleman Disease - pathology</topic><topic>Cell Proliferation - drug effects</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial Cells - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Interleukin-6 - blood</topic><topic>Kidney Glomerulus - drug effects</topic><topic>Kidney Glomerulus - metabolism</topic><topic>Kidney Glomerulus - pathology</topic><topic>Treatment Outcome</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wakabayashi, Keiichi</creatorcontrib><creatorcontrib>Asanuma, Katsuhiko</creatorcontrib><creatorcontrib>Takeda, Yukihiko</creatorcontrib><creatorcontrib>Arakawa, Atsushi</creatorcontrib><creatorcontrib>Osawa, Isao</creatorcontrib><creatorcontrib>Horikoshi, Satoshi</creatorcontrib><creatorcontrib>Yao, Takashi</creatorcontrib><creatorcontrib>Tomino, Yasuhiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wakabayashi, Keiichi</au><au>Asanuma, Katsuhiko</au><au>Takeda, Yukihiko</au><au>Arakawa, Atsushi</au><au>Osawa, Isao</au><au>Horikoshi, Satoshi</au><au>Yao, Takashi</au><au>Tomino, Yasuhiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells</atitle><jtitle>Clinical nephrology</jtitle><addtitle>Clin Nephrol</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>81</volume><issue>6</issue><spage>445</spage><epage>450</epage><pages>445-450</pages><issn>0301-0430</issn><abstract>Castleman’s disease (CD) is a lymphoproliferative disorder of uncertain etiology. It can be classified histopathologically as hyaline vascular (HV) or plasma cell (PC) type; and clinically as unicentric or multicentric. Multicentric CD mostly manifests as the PC type and is often associated with a variety of systemic complications, although renal complications are uncommon. We present here a case of HV type, unicentric CD with a variety of systemic and renal complications, including the proliferation of glomerular endothelial cells. Various cytokines are thought to be involved in the etiology of this disease, especially interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), which are the main cytokines inducing systemic complications. It has been reported that most PC types and/or multicentric types of CD show increasing levels of serum IL-6 and VEGF, as well as systemic symptoms. Although the current case showed high serum IL-6 and VEGF levels as well as systemic symptoms, the pathological and clinical type were of the HV type and unicentric type, respectively. After immunosuppressive therapy, the serum levels of IL-6 and VEGF returned to the normal range, and systemic complications, including renal involvement, also improved. We report the possibility of pathogenesis via the serum and the pathology of this rare case.</abstract><cop>Germany</cop><pmid>23211339</pmid><doi>10.5414/CN107705</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-0430
ispartof Clinical nephrology, 2014-06, Vol.81 (6), p.445-450
issn 0301-0430
language eng
recordid cdi_proquest_miscellaneous_1545189808
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Biomarkers - blood
Biopsy
Castleman Disease - blood
Castleman Disease - drug therapy
Castleman Disease - pathology
Cell Proliferation - drug effects
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Endothelial Cells - pathology
Female
Humans
Immunohistochemistry
Immunosuppressive Agents - therapeutic use
Interleukin-6 - blood
Kidney Glomerulus - drug effects
Kidney Glomerulus - metabolism
Kidney Glomerulus - pathology
Treatment Outcome
Vascular Endothelial Growth Factor A - blood
title Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A48%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyaline%20vascular%20type%20of%20unicentric%20Castleman's%20disease%20with%20proliferation%20of%20glomerular%20endothelial%20cells&rft.jtitle=Clinical%20nephrology&rft.au=Wakabayashi,%20Keiichi&rft.date=2014-06-01&rft.volume=81&rft.issue=6&rft.spage=445&rft.epage=450&rft.pages=445-450&rft.issn=0301-0430&rft_id=info:doi/10.5414/CN107705&rft_dat=%3Cproquest_pubme%3E1545189808%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1545189808&rft_id=info:pmid/23211339&rfr_iscdi=true